iShares U.S. Pharmaceuticals ETF (IHE)
| 186.91 Delayed Data As of Jan 21 |  -1.52 / -0.81%Today’s Change | 170.37 Today|||52-Week Range 201.24 | -6.37% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.
Latest IHE News
| Arlington Financial Advisors, LLC Buys FIRST TR EXCHANGE, Apple Inc, iShares MSCI All Country ... Jan 18 / GuruFocus News - Paid Partner Content | Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit Jan 11 / Zacks.com - Paid Partner Content |
Performance
| 1 month | -5.23% | 3 years | +9.68% | |
| 3 months | +0.40% | 5 years | +7.32% | |
| 1 year | +3.25% | Since inception | +10.28% |
Data through 01/22/2022
Quote Details
| Previous close | $188.43 |
| Open day’s range | 186.81 – 187.38 |
| Net asset value (NAV) | 186.36 (01/21/2022) |
| Daily volume | 5,500 |
| Average volume (3 months) | 7,422 |
Data as of 3:48pm ET, 01/21/2022
Peer Comparisonvs. Health ETFs
| IHE | Category | |
|---|---|---|
| Performance 5-yr return | +7.32% | +15.55% |
| Expense Gross exp ratio | 0.42% | 1.01% |
| Risk 5 year sharpe ratio | 0.54 | 0.85 |
| Net assets | $399.0M | $2.3B |
| Average market cap | $77.2B | $37.5B |
| Average P/E | 19.7 | 23.2 |
| Dividend / Share | -- | 0.29% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| RYH Invesco S&P 500® Equal Weight Health Ca... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 98.99% |
| Consumer goods | 1.01% |
| Business service | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| PFE Pfizer | 23.45% |
| JNJ Johnson & Johnson | 21.99% |
| LLY Eli Lilly and Co | 4.78% |
| VTRS Viatris Inc | 4.60% |
| BMY Bristol-Myers Squibb | 4.57% |
| ZTS Zoetis Inc | 4.49% |
| MRK Merck | 4.42% |
| RPRX Royalty Pharma PLC | 4.30% |
| CTLT Catalent Inc | 4.24% |
| ELAN Elanco Animal Health Inc | 4.06% |
